Dose reduction is a feasible strategy in patients with plaque psoriasis who achieve sustained response with secukinumab: a retrospective, multicenter cohort study in daily practice setting Academic Article 2024 uri icon

authors

  • Esteban Daudén
  • Antonio Martorell
  • Ferran Ballesca
  • BELINCHON ROMERO, ISABEL
  • Gregorio Carretero
  • Lourdes Rodríguez
  • Alberto Romero-Mate
  • J. Pujol-Montcusí
  • Laura Salgado
  • Antonio Sahuquillo-Torralba
  • Pablo Coto-Segura
  • Elena Escario MD
  • Ofelia Baniandres
  • R. Feltes
  • Josep Riera-Monroig M
  • Jesus Garrido
  • Mar Llamas-Velasco
  • Luisa Martos-Cabrera
  • Susana Armesto
  • Enrique Herrera-Acosta
  • David Vidal
  • Eva Vilarrasa
  • Raquel Rivera
  • Pablo de la Cueva

publication date

  • 2024